SIRPA and neoplasm: Another approach for modulating the phagocytic action of macrophages in the tumor microenvironment is through inhibition of the binding of CD47, a transmembrane protein widely expressed by tumor cells, to the signal regulatory protein alpha [SIRP-alpha] on the macrophage surfaces through anti-CD47 monoclonal antibodies [TTI-621, NCT049996004] [35].